|D. Henry, MD, Graduate Hospital, Philadelphia, PA, proposes using a battery of three factors to predict whether or not an anemic cancer patient receiving chemotherapy will respond to epoetin alpha (EA). The likelihood of an increase in hemoglobin of 2 g/dL or more depends on the hemoglobin change at 4 weeks, blood transfusion status, and observed/predicted EA ratio. Data on 752 anemic cancer patients led to developing this model.|
|Introduction||EA can increase hemoglobin and/or decrease the need for blood transfusion in 53.4% of anemic patients. Several investigators tried to predict who would respond before or soon after treatment with EA (Ludwig, Cazzola, Osterborg, Henry, and Glaspy).|
|Study Protocol||A pool of 2030 cancer patients treated with EA served to provide a random sample of 752 records for analysis. Each patient record gave information on hemoglobin change after 4 weeks' treatment, transfusion dependence, and baseline pretreatment epoetin level. Beguin's method (Brit J Hematol 1992;82:648) allowed calculating the predicted epoetin levels from EA administration. The equation is log predicted epoietin level = 3.420 - (0.056 x % hematocrit). Henry defined a positive response to EA therapy as an increase in hemoglobin of at least 2 g/dL.|
The following calculations support Henry's proposal:|
The likelihood of an increase in hemoglobin of 2 g/dL or more from EA may be predicted at the 85% level by using all three measures.
|Comments||The investigator's proposed method for predicting response to EA
seems simple and direct but requires hemoglobin and blood
transfusion data as late as 4 weeks. An earlier decision point
would enhance the value of the method. Clinical application of the
procedure awaits prospective data collection.
For professional correspondence, please contact Dr. Henry at: firstname.lastname@example.org
Presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) on May 17-20, 1997
CONRAD NOTES, © 1997 All Rights Reserved
Eugene A. Conrad, PhD, MPH / ISSN 1078 / June 1997